The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Dimed Distribuidora de Medicamentos's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.48.
The historical rank and industry rank for Dimed Distribuidora de Medicamentos's Dividend Payout Ratio or its related term are showing as below:
BSP:PNVL3'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.07 Med: 0.3 Max: 0.79
Current: 0.4
During the past 13 years, the highest Dividend Payout Ratio of Dimed Distribuidora de Medicamentos was 0.79. The lowest was 0.07. And the median was 0.30.
BSP:PNVL3's Dividend Payout Ratio is ranked worse than 52.03% of 444
companies
in the Drug Manufacturers industry
Industry Median: 0.375
vs BSP:PNVL3: 0.40
During the past 13 years, the highest Trailing Annual Dividend Yield of Dimed Distribuidora de Medicamentos was 5.61%. The lowest was 0.10%. And the median was 1.25%.
During the past 12 months, Dimed Distribuidora de Medicamentos's average Dividends Per Share Growth Rate was -18.20% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 15.90% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 48.70% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 10.20% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Dimed Distribuidora de Medicamentos was 51.50% per year. The lowest was -43.40% per year. And the median was 15.90% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Dimed Distribuidora de Medicamentos (BSP:PNVL3) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Dimed Distribuidora de Medicamentos Dividend Payout Ratio Related Terms
Dimed Distribuidora de Medicamentos Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dimed Distribuidora de Medicamentos Dividend Payout Ratio Chart
BSP:PNVL3 vs LLY, JNJ, ABBV: Dividend Payout Ratio Comparison
For the Drug Manufacturers - General subindustry, Dimed Distribuidora de Medicamentos's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dimed Distribuidora de Medicamentos Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dimed Distribuidora de Medicamentos's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Dimed Distribuidora de Medicamentos's Dividend Payout Ratio falls into.
Dimed Distribuidora de Medicamentos Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dimed Distribuidora de Medicamentos (BSP:PNVL3) has a Dividend Payout Ratio of 0.48 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Dimed Distribuidora de Medicamentos and its competitors. This is 60% above median its historical median of 0.30. Over the past decade, Dimed Distribuidora de Medicamentos' Dividend Payout Ratio has ranged from 0.07 to 0.79. According to the industry distribution chart, Dimed Distribuidora de Medicamentos ranks #231 out of 444 companies in the Drug Manufacturers industry, placing it in the top 52%.
Is Dimed Distribuidora de Medicamentos' Dividend Payout Ratio too high?
Dimed Distribuidora de Medicamentos' current Dividend Payout Ratio of 0.48 is 60% above median its 10-year median of 0.30. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 0.79. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Dimed Distribuidora de Medicamentos' value of 0.48 is 28% above this industry median. Based on the distribution chart, Dimed Distribuidora de Medicamentos ranks #231 out of 444 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Dimed Distribuidora de Medicamentos has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dimed Distribuidora de Medicamentos' Dividend Payout Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Dimed Distribuidora de Medicamentos ranks #231 out of 444 companies for Dividend Payout Ratio. This places Dimed Distribuidora de Medicamentos in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Dimed Distribuidora de Medicamentos' value of 0.48 is 28% above this benchmark. Historically, Dimed Distribuidora de Medicamentos' own Dividend Payout Ratio has ranged from 0.07 to 0.79 over the past decade. While the company's 10-year median is 0.30 vs. the industry median of 0.38, Dimed Distribuidora de Medicamentos has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dimed Distribuidora de Medicamentos's current Dividend Payout Ratio of 0.48 is 28% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Dimed Distribuidora de Medicamentos and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dimed Distribuidora de Medicamentos's current Dividend Payout Ratio is 0.48, which is 60% above median its own 10-year median of 0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dimed Distribuidora de Medicamentos stock overvalued right now?
Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos (BSP:PNVL3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$13.55, compared to a current price of R$10.84 — trading 20% below its estimated fair value. The current Dividend Payout Ratio is 0.48, which is 60% above median its 10-year median of 0.30 and 28% above the Drug Manufacturers industry median of 0.38. Dimed Distribuidora de Medicamentos' overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Dimed Distribuidora de Medicamentos (BSP:PNVL3), the current Dividend Payout Ratio is 0.48 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dimed Distribuidora de Medicamentos (BSP:PNVL3) Overvalued in 2026?
Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos stock appears to be undervalued.
The current stock price of R$10.84 is trading 20% below its estimated GF Value™ of R$13.55.
GuruFocus considers Dimed Distribuidora de Medicamentos to be Modestly Undervalued.
Key valuation signals for BSP:PNVL3:
Dividend Payout Ratio: 0.48 (60% above median its 10-year median of 0.30)
GF Value™: R$13.55 vs. price of R$10.84 (20% below fair value)
Industry Position: 28% above the Drug Manufacturers median (#231 of 444)
No single metric tells the full story. See the BSP:PNVL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dimed Distribuidora de Medicamentos Business Description
Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. It has single reportable segment that is, The Retail segment. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.
89GF Score
Get the complete analysis for BSP:PNVL3
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:PNVL3 has been successfully added to your 
